Comments on the FDA draft guidance on biosimilar products
Crossref DOI link: https://doi.org/10.1002/sim.5572
Published Online: 2012-08-18
Published Print: 2013-02-10
Update policy: https://doi.org/10.1002/crossmark_policy
Chow, SheinâChung
Endrenyi, Laszlo
Lachenbruch, Peter A.
Version of Record valid from 2012-08-18
Text and Data Mining valid from 2015-09-01